We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. No prescription was prescribed in 82% of the dermatology ...

Please provide your email address to receive an email when new articles are posted on . Older patients and patients with diabetes had longer duration to cure of onychomycosis, according to a study ...

Medically reviewed by Danielle McNeil, D.P.M Key Takeaways Subungual onychomycosis is the most common type of toenail fungus and affects the nail bed and underside of the nail. White superficial ...

There appear to be no differences in efficacy or safety between pulse and continuous regimens of terbinafine and no differences between pulse and continuous regimens of itraconazole for dermatophyte ...

Onychomycosis is the most common disease of nails, with a prevalence of up to 14% in Western adult populations. Whereas tinea unguium refers strictly to dermatophyte fungal infection of the nail plate ...

WASHINGTON, Jan. 31, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug ...

A study published in the Journal of Drugs in Dermatology compared the clinical cure rates associated with continuous- versus pulse-dose terbinafine regimens for toenail onychomycosis. Sixty patients ...

Because of increasing antifungal resistance, an accurate diagnosis is important to provide appropriate treatment to patients with onychodystrophy. To identify factors associated with ...